Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Precedings
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • RSS feed
  1. nature
  2. nature precedings
  3. articles
  4. article
Reducing the Probability of False Positive Research Findings by Pre-Publication Validation - Experience with a Large Multiple Sclerosis Database
Download PDF
Download PDF
  • Manuscript
  • Open access
  • Published: 12 July 2007

Reducing the Probability of False Positive Research Findings by Pre-Publication Validation - Experience with a Large Multiple Sclerosis Database

  • Martin Daumer PhD1,
  • Ulrike Held PhD1,
  • Katja Ickstadt PhD2,
  • Moritz Heinz PhD3,
  • Siegfried Schach2 &
  • …
  • George Ebers MD, PhD4 

Nature Precedings (2007)Cite this article

  • 394 Accesses

  • 1 Citations

  • Metrics details

Abstract

*Objective*

We have assessed the utility of a pre-publication validation policy in reducing the probability of publishing false positive research findings. *Study design and setting*The large database of the Sylvia Lawry Centre for Multiple Sclerosis Research was split in two parts: one for hypothesis generation and a validation part for confirmation of selected results. We present case studies from 5 finalized projects that have used the validation policy and results from a simulation study.

*Results*

In one project, the "relapse and disability" project as described in section II (example 3), findings could not be confirmed in the validation part of the database. The simulation study showed that the percentage of false positive findings can exceed 20% depending on variable selection. *Conclusion*We conclude that the validation policy has prevented the publication of at least one research finding that could not be validated in an independent data set (and probably would have been a "true" false-positive finding) over the past three years, and has led to improved data analysis, statistical programming, and selection of hypotheses. The advantages outweigh the lost statistical power inherent in the process.

Similar content being viewed by others

Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease

Article Open access 24 June 2024

Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning

Article Open access 26 September 2022

Performance of machine learning models for predicting high-severity symptoms in multiple sclerosis

Article Open access 25 May 2025

Article PDF

Author information

Authors and Affiliations

  1. Sylvia Lawry Centre for MS Research, Hohenlindener Str. 1, 81677 Munich, Germany

    Martin Daumer PhD & Ulrike Held PhD

  2. Department of Statistics, University of Dortmund, 44221 Dortmund, Germany

    Katja Ickstadt PhD & Siegfried Schach

  3. Institute for Medical Biometry, Epidemiology and Computer Science, Clinic of Gutenberg’s University Mainz, Germany

    Moritz Heinz PhD

  4. University Dept of Clinical Neurology, Oxford University, UK

    George Ebers MD, PhD

Authors
  1. Martin Daumer PhD
    View author publications

    Search author on:PubMed Google Scholar

  2. Ulrike Held PhD
    View author publications

    Search author on:PubMed Google Scholar

  3. Katja Ickstadt PhD
    View author publications

    Search author on:PubMed Google Scholar

  4. Moritz Heinz PhD
    View author publications

    Search author on:PubMed Google Scholar

  5. Siegfried Schach
    View author publications

    Search author on:PubMed Google Scholar

  6. George Ebers MD, PhD
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Martin Daumer PhD.

Rights and permissions

Creative Commons Attribution 2.5 License.

Reprints and permissions

About this article

Cite this article

Daumer, M., Held, U., Ickstadt, K. et al. Reducing the Probability of False Positive Research Findings by Pre-Publication Validation - Experience with a Large Multiple Sclerosis Database. Nat Prec (2007). https://doi.org/10.1038/npre.2007.433.1

Download citation

  • Received: 12 July 2007

  • Accepted: 12 July 2007

  • Published: 12 July 2007

  • DOI: https://doi.org/10.1038/npre.2007.433.1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Validation testing
  • Multiple Sclerosis
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Precedings (Nat Preced)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing